Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2010 Feb 4;43(10):539–548. doi: 10.1007/s11094-010-0348-2

Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review)

L A Baltina 1,✉, R M Kondratenko 2, L A Baltina Jr 1, O A Plyasunova 3, A G Pokrovskii 3, G A Tolstikov 1
PMCID: PMC7089237  PMID: 32214533

Abstract

The review is devoted to the problem of creating new antiviral drugs based on glycyrrhizic acid (GA), the major triterpene glycoside extracted from roots of common and Ural licorice (Glycyrrhiza glabra L. and G. uralensis Fisher, respectively). Published data on the natural GA sources, antiviral activity of GA and its derivatives, clinical applications of GA-based drugs, and the properties of GA-containing biologically active nutrient additives are summarized. Possible mechanisms of the antiviral activity of GA and its derivatives are examined. It is shown that chemical modification of GA is a promising way of designing new highly active antiviral drugs for the prophylaxis and treatment of HIV, hepatitis B and C, corona-virus, and herpes simplex virus infections.

Key words: licorice root, glycyrrhizic acid, antiviral activity, antiviral drugs, biologically active nutrient additives

Footnotes

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 43, No. 10, pp. 3–12, October, 2009.

References

  • 1.Ershov FI. Antiviral Preparations. Moscow: Meditsina; 1998. [Google Scholar]
  • 2.F. I. Ershov and N. V. Kas’yanova, Consilium Medicum, 6(1) (2004); http://www.consilium-medicum.com.
  • 3.Matthee G, Wright AD, Konig GM. Planta Med. 1999;65(6):493–506. doi: 10.1055/s-1999-14004. [DOI] [PubMed] [Google Scholar]
  • 4.Corbett JW. Curr. Med. Chem.: Anti Infect. Agents. 2003;1(2):119–140. doi: 10.2174/1568012023354938. [DOI] [Google Scholar]
  • 5.Imamichi T. Front. Med. Chem. 2006;3:23–44. [Google Scholar]
  • 6.Domingo P, Vidal F, Domingo JC. Curr. Med. Chem.: Anti Infect. Agents. 2004;3(2):109–133. doi: 10.2174/1568012043354053. [DOI] [Google Scholar]
  • 7.Tandon VK, Chhor RB. Curr. Med. Chem.: Anti Infect. Agents. 2005;4(1):3–28. doi: 10.2174/1568012052931250. [DOI] [Google Scholar]
  • 8.Fisenko VP, Drozhzhin AP, Abidov MT. Analysis of the Most Promising Research on the Creation of New Drugs. Moscow: NTsEGKLS; 2000. [Google Scholar]
  • 9.Russian Therapeutic Handbook [in Russian], GEOTAR-Media, Moscow (2005).
  • 10.Mashkovskii MD. Drugs. Moscow: Novaya Volna; 2000. [Google Scholar]
  • 11.Manfredi R, Sabbatani S. Curr. Med. Chem. 2006;13(20):2369–2384. doi: 10.2174/092986706777935069. [DOI] [PubMed] [Google Scholar]
  • 12.Balsano C, Alisi A. Curr. Med. Chem. 2008;15(9):930–939. doi: 10.2174/092986708783955383. [DOI] [PubMed] [Google Scholar]
  • 13.Del Vecchio AM, Sarisky RT. Mini-Reviews Med. Chem. 2006;6(11):1263–1268. doi: 10.2174/138955706778742786. [DOI] [PubMed] [Google Scholar]
  • 14.Matsuo K, Takenaka K, Shimomura H, et al. Leuk. Lymphoma. 2001;41:191–195. doi: 10.3109/10428190109057970. [DOI] [PubMed] [Google Scholar]
  • 15.Butler MS. J. Nat. Prod. 2004;67(12):2141–2153. doi: 10.1021/np040106y. [DOI] [PubMed] [Google Scholar]
  • 16.Butler MS. Nat. Prod. Res. 2005;22:162–195. doi: 10.1039/b402985m. [DOI] [PubMed] [Google Scholar]
  • 17.Vidal Handbook. Drugs in Russia: Handbook [in Russian], AstraFarmServis, Moscow (2005).
  • 18.Encyclopedia of Drugs [in Russian], OOO RLS-2005, Moscow (2004).
  • 19.Salo VM. Man’s Green Friends. Moscow: Nauka; 1975. [Google Scholar]
  • 20.Volynskii BG, Bender KI, Freidman SL, et al. Medicinal Plants in Scientific and Folk Medicine. Saratov: Izd. Saratov. Univ.; 1972. [Google Scholar]
  • 21.Tolstikov GA, Shul’ts EE, Baltina LA, Tolstikova TG. Khim. Interesakh Ustoich. Razvit. 1997;5:57–73. [Google Scholar]
  • 22.Study and Use of Licorice in the USSR Economy [in Russian], Gylym, Alma-Ata (1991).
  • 23.A. I. Isambaev, B. N. Saurambaev, E. V. Kuz’min, and M. K. Kukenov, Licorice - A Valuable Medicinal-Industrial Plant Indigenous to Kazakhstan [in Russian], Alma-Ata (1991).
  • 24.Grankina VP, Nadezhina GP. Ural Licorice. Novosibirsk: Nauka, Sib. Br; 1991. [Google Scholar]
  • 25.Vichkanova SA, Rubinchik MA. Licorice Root. Moscow: Meditsina; 1978. [Google Scholar]
  • 26.E. A. Kurganova, Tr. BIN Akad. Nauk SSSR, Ser. 1, No. 11, 164–167 (1995).
  • 27.Kurganova EA. Problems of the Study and Use of Licorice in the USSR Economy. Moscow-Leningrad: Nauka; 1966. pp. 19–26. [Google Scholar]
  • 28.Murav’ev IA, Sokolov VS. Problems of the Study and Use of Licorice in the USSR Economy. Moscow-Leningrad: Nauka; 1966. pp. 5–14. [Google Scholar]
  • 29.Kucherov EV, Lazareva DN, Desyatkin VK. Medicinal Plants of Bashkiria: Their Use and Protection. Ufa: Bashkir. Knizhnoe Izd.; 1990. [Google Scholar]
  • 30.Rare and Threatened Species of the USSR Flora Needing Protection [in Russian], Nauka, Leningrad (1990).
  • 31.Sokolov S Ya, Zamotaev IP. Handbook of Medicinal Plants. Moscow: Meditsina; 1988. [Google Scholar]
  • 32.Ammosov AS, Timofeeva VV, Litvinenko VI. Rastit. Resur. 1984;20(2):248–251. [Google Scholar]
  • 33.USSR State Pharmacopoeia, USSR Min. Health, XI Ed., Vneshtorgizdat, Moscow (1991).
  • 34.Lebeda AF, Dzhurenko NI, Isaikina AP, Sobko VG. Medicinal Plants: A Complete Encyclopedia. Moscow: AST-PRESS KNIGA; 2004. [Google Scholar]
  • 35.USSR State Pharmacopoeia, USSR, Min. Health, Xth Ed., Meditsina, Moscow (1987), pp. 24–31 (1999).
  • 36.Muravev IA. Farm. Pol. 1967;23(7–8):798–803. [Google Scholar]
  • 37.A. S. Ammosov, V. I. Litvinenko, and T. P. Popova, Gos. NII Ekon. Med. Prom’st, No. 1, 1–9 (1998).
  • 38.I. A. Murev’ev and A. K. Tsaturyan, Current Problems in Pharmacy [in Russian], Alma-Ata (1989), pp. 88–89.
  • 39.Statti GA, Tundis R, Sacchetti G, et al. Fitoterapia. 2004;75(3–4):371–374. doi: 10.1016/j.fitote.2003.12.022. [DOI] [PubMed] [Google Scholar]
  • 40.Hayashi H, Hattori S, Inoue K, et al. Chem. Pharm. Bull. 2003;51(11):1338–1340. doi: 10.1248/cpb.51.1338. [DOI] [PubMed] [Google Scholar]
  • 41.Ammosov AS, Litvinenko VI. Rastit. Resur. 1995;31(3):116–145. [Google Scholar]
  • 42.Ammosov AS, Litvinenko VI. Khim.-farm. Zh. 2003;37(2):31–42. [Google Scholar]
  • 43.Georgievskii VP, Komissarov NF, Dmitruk SE. Biologically Active Compounds from Medicinal Plants. Novosibirsk: Nauka; 1990. [Google Scholar]
  • 44.Tyler VE. Pharmacognosy. 9. Philadelphia: Len & Febiger; 1988. [Google Scholar]
  • 45.Shibata S. J. Pharm. Soc. Jpn. 2000;120(10):849–862. doi: 10.1248/yakushi1947.120.10_849. [DOI] [PubMed] [Google Scholar]
  • 46.Kitagawa I. Pure Appl. Chem. 2002;74(7):1189–1198. doi: 10.1351/pac200274071189. [DOI] [Google Scholar]
  • 47.Obolentseva GV, Litvinenko VI, Ammosov AS. Khim.-farm. Zh. 1999;33(8):24–31. [Google Scholar]
  • 48.Tolstikov GA, Baltina LA, Shul’ts EE, Pokrovskii AG. Bioorg. Khim. 1997;23(9):691–709. [PubMed] [Google Scholar]
  • 49.Tolstikov GA, Goryaev MI. Glycyrrhetic Acid. Alma-Ata: Nauka; 1966. [Google Scholar]
  • 50.Tolstikov GA, Baltina LA, Serdyuk NG. Khim.-farm. Zh. 1998;32(8):5–14. [Google Scholar]
  • 51.H. A. V. Hartung, USA Pat. No. 4,176,228, Nov. 27, 1979; Chem. Abstr., 92, 145286g (1980).
  • 52.L. M. Khalilov, L. A. Baltina, L. V. Spirikhin, et al., Khim. Prir. Soedin., No. 4, 500–505 (1989).
  • 53.Baltina LA, Kunert O, Fatykhov AA, et al. Khim. Prir. Soedin. 2005;4:347–350. [Google Scholar]
  • 54.G. A. Tolstikov and M. P. Irismetov, Izv. Akad. Nauk Kaz. SSR, Ser. Khim., No. 4, 53–61 (1984).
  • 55.E. V. Buranova, U. A. Turumbetov, and S. M. Adekenov, Phytochemistry for Development of the Pharmacy Industry, Proceedings of a Republic Scientific-Practical Conf. Dedicated to the 60-th Birthday of Famous Scientist M. N. Mukhametzhanov [in Russian], Karaganda (2000), pp. 236–238.
  • 56.World Health Organization, Radix Glycyrrizae Monographs on Selected Medicinal Plants, Vol. 1, Geneva (1999), pp. 183–194.
  • 57.Kapadia GJ, Azune MA, Tokuda H, et al. Pharmacol. Res. 2002;45(3):213–220. doi: 10.1006/phrs.2001.0936. [DOI] [PubMed] [Google Scholar]
  • 58.Coon JT, Ernst E. J. Hepatol. 2004;40(3):491–500. doi: 10.1016/j.jhep.2003.11.014. [DOI] [PubMed] [Google Scholar]
  • 59.Badam L. J. Commun. Diseas. 1997;29(2):91–99. [PubMed] [Google Scholar]
  • 60.Bradbury J. Lancet. Infect. Dis. 2005;5(4):201. doi: 10.1016/S1473-3099(05)70040-2. [DOI] [PubMed] [Google Scholar]
  • 61.E. S. Mirza-zade and N. S. Nagieva, http://interstom.narod.ru/solodka.html.
  • 62.Pompei R. Riv. Farmacol. Ter. 1979;10(3):281–284. [Google Scholar]
  • 63.Pompei R, Pani A, Flore O, et al. Experientia. 1980;36(3):304. doi: 10.1007/BF01952290. [DOI] [PubMed] [Google Scholar]
  • 64.Pompei R, Flore O, Pani A, et al. Riv. Farmacol. Ter. 1979;10(4):355–359. [Google Scholar]
  • 65.Pompei R, Flore O, Marcialis M, et al. Nature (London) 1979;281(5733):689–690. doi: 10.1038/281689a0. [DOI] [PubMed] [Google Scholar]
  • 66.Pompei R, Paghi L, Ingianni A, Uccheddu P. Microbiologica. 1983;6(3):247–250. [PubMed] [Google Scholar]
  • 67.Pompei R. Riv. Farmacol. Ter. 1981;12(1):43–46. [Google Scholar]
  • 68.Baba M, Shigeta S. Antiviral Res. 1987;7(2):99–107. doi: 10.1016/0166-3542(87)90025-8. [DOI] [PubMed] [Google Scholar]
  • 69.Badam L. Nat. Med. J. India. 1997;10(2):98. [PubMed] [Google Scholar]
  • 70.Utsunomiya T, Kobayashi M, Herndon DN, et al. Immunol. Lett. 1995;44:59–66. doi: 10.1016/0165-2478(94)00183-R. [DOI] [PubMed] [Google Scholar]
  • 71.Ceremelli C, Portolani M, Cotombari B, et al. Phytochem. Res. 1996;10:527–528. [Google Scholar]
  • 72.Numazaki K, Nagata N, Sato T, Chiba S. J. Leukocyte Biol. 1994;55:24–28. doi: 10.1002/jlb.55.1.24. [DOI] [PubMed] [Google Scholar]
  • 73.Crance J-M, Leveque F, Biziagos E, et al. Antiviral Res. 1994;23:63–76. doi: 10.1016/0166-3542(94)90033-7. [DOI] [PubMed] [Google Scholar]
  • 74.Sato H, Goto W, Yamamura J-I, et al. Antiviral Res. 1996;30:171–177. doi: 10.1016/0166-3542(96)00942-4. [DOI] [PubMed] [Google Scholar]
  • 75.Arase Y, Ikeda K, Murashima N, et al. Cancer. 1997;79(8):1494–1500. doi: 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  • 76.Lin J-C. Antiviral Res. 2003;59:41–47. doi: 10.1016/S0166-3542(03)00030-5. [DOI] [PubMed] [Google Scholar]
  • 77.Cinatl J, Morgenstern B, Bauer G, et al. Lancet. 2003;361(6):2045–2046. doi: 10.1016/S0140-6736(03)13615-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.M. Ito, H. Nakashima, N. Yamamoto, et al., Eur. Pat. No. 255,420 (1988); Chem. Abstr., 109, 116062v (1988).
  • 79.M. Ito, H. Nakashima, M. Baba, et al., Jpn. Pat. Appl. No. 63–3332 (1988); Ref. Zh. Khim., 6 O 209P (1989).
  • 80.Ito M. Jikken Igaku. 1989;7(7):858–860. [Google Scholar]
  • 81.Ito M, Nakashima H, Baba M, et al. Antiviral Res. 1987;7(3):127–137. doi: 10.1016/0166-3542(87)90001-5. [DOI] [PubMed] [Google Scholar]
  • 82.De Clerq E. Trends Pharmacol. Sci. 1987;8(9):339–345. doi: 10.1016/0165-6147(87)90143-X. [DOI] [Google Scholar]
  • 83.Ito M, Nakashima H, Baba M, et al. Igaku no Ayumi. 1987;141(7):427–428. [Google Scholar]
  • 84.De Clerq E. Med. Res. Rev. 2000;20(5):323–349. doi: 10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  • 85.De Clerq E. J. Med. Chem. 1995;38(14):2491–2517. doi: 10.1021/jm00014a001. [DOI] [PubMed] [Google Scholar]
  • 86.Vlietinck AJ, De Bruyne T, Apers S, Pieters LA. Planta Med. 1998;64:97–109. doi: 10.1055/s-2006-957384. [DOI] [PubMed] [Google Scholar]
  • 87.Ito M, Sato A, Hirabayashi K, et al. Antiviral Res. 1988;10(6):289–298. doi: 10.1016/0166-3542(88)90047-2. [DOI] [PubMed] [Google Scholar]
  • 88.Ueno R., Ueno R., Kuno S. Chem. Abstr. 1990;112:84180a. [Google Scholar]
  • 90.O. A. Plyasunova, Candidate Dissertation in Biological Sciences as a Scientific Paper, Kol’tsovo (1992).
  • 90.Hattori T, Ikumatsu S, Koivo A, et al. Antiviral Res. 1989;11(5–6):255–261. doi: 10.1016/0166-3542(89)90035-1. [DOI] [PubMed] [Google Scholar]
  • 91.Ikegami N, Kinoshita S, Kanesaki T, Uno K, Akatani K, Kishida T. Antiviral Res. 1996;30(1):33. doi: 10.1016/0166-3542(96)80279-8. [DOI] [Google Scholar]
  • 92.Plyasunova OA, Mamaeva OA, Gashnikova NM, et al. VICh/SPID Rodstv. Probl. 1999;3(1):58. [Google Scholar]
  • 93.O. A. Plyasunova, I. N. Egoricheva, N. V. Fedyuk, et al., Vopr. Virusol., No. 5–6, 235–238 (1992).
  • 94.Miyamoto K., Okuda T., Hirabayashi K. Chem. Abstr. 1990;115:41976j. [Google Scholar]
  • 95.T. S. Tochikura, H. Nakashima, and N. Yamamoto, J. Acquired Immune Defic. Syndr., No. 2, 441–447 (1989). [PubMed]
  • 96.Y. Isowa, Y. Sato, Y. Nakajima, and N. Yamamoto, Jpn. Pat. No. 63243093, Oct. 7, 1988; Chem. Abstr., 111, P58268v (1989).
  • 97.D. Yasiro and M. Matida, Jpn. Pat. Appl. No. 1–238525 (1989); Ref. Zh. Khim., 5 O 258P (1990).
  • 98.Saito S, Furumoto T, Ochiai M, et al. Eur. J. Med. Chem. 1996;31:365–381. doi: 10.1016/0223-5234(96)89163-X. [DOI] [Google Scholar]
  • 99.Hirabayashi K, Iwata S, Matsumoto H, et al. Chem. Pharm. Bull. 1991;39(1):112–115. doi: 10.1248/cpb.39.112. [DOI] [PubMed] [Google Scholar]
  • 100.Tolstikov GA, Baltina LA, Ryzhova SA, et al. Abstracts of Comm. of International Conf. on Molecular Biology Aspects of Diagnostics and Therapy of AIDS. Novosibirsk: Academgorodok; 1991. p. 14. [Google Scholar]
  • 101.G. A. Tolstikov, L. A. Baltina, A. G. Pokrovskii, et al., RF Pat. No. 2,024,544 (1991); Byull. Izobret., No. 23 (1994).
  • 102.L. A. Baltina, A. G. Pokrovskii, O. A. Plyasunova, and G. A. Tolstikov, RF Pat. No. 2,024,542 (1991); Byull. Izobret., No. 23 (1994).
  • 103.G. A. Tolstikov, L. A. Baltina, A. G. Pokrovskii, et al., RF Pat. No. 2,024,546 (1991); Byull. Izobret., No. 23 (1994).
  • 104.G. A. Tolstikov, L. A. Baltina, A. G. Pokrovskii, et al., RF Pat. No. 2,024,545 (1991); Byull. Izobret., No. 23 (1994).
  • 105.L. A. Baltina, A. G. Pokrovskii, O. A. Plyasunova, and G. A. Tolstikov, RF Pat. No. 2,024,547 (1991); Byull. Izobret., No. 23 (1994).
  • 106.L. A. Baltina, A. G. Pokrovskii, O. A. Plyasunova, and G. A. Tolstikov, RF Pat. No. 2,024,543 (1991); Byull. Izobret., No. 23 (1994).
  • 107.R. M. Kondratenko, L. A. Baltina, S. R. Mustafina, et al., RF Pat. No. 2,199,547 (2001); Byull. Izobret., No. 6 (2003).
  • 108.R. M. Kondratenko, L. A. Baltina, O. A. Plyasunova, et al., RF Pat. No. 2,198,177 (2001); Byull. Izobret., No. 4 (2003).
  • 109.Baltina LA. Curr. Med. Chem. 2003;10(2):155–171. doi: 10.2174/0929867033368538. [DOI] [PubMed] [Google Scholar]
  • 110.T. V. Il’ina, E. A. Semenova, O. A. Plyasunova, et al., Byull. Sib. Otd. Ross. Akad. Med. Nauk, No. 2, 20–24 (2002).
  • 111.A. G. Pokrovskii, O. A. Plyasunova, T. N. Il’icheva, et al., Khim. Interesakh Ustoich. Razvit., No. 9, 485–491 (2001).
  • 112.Kondratenko RM, Baltina LA, Mustafina SR, et al. Bioorg. Khim. 2004;30(3):308–315. doi: 10.1023/b:rubi.0000030135.97089.37. [DOI] [PubMed] [Google Scholar]
  • 113.Baltina LA, Plyasunova OA, Pokrovskii AG, et al. Abstracts of Papers of the Xth Russian Nat. Congr. Man and Medicine. Moscow: RTs Farmedinfo; 2003. p. 693. [Google Scholar]
  • 114.A. G. Pokrovskii, O. A. Plyasunova, L. A. Baltina, et al., USSR Pat. No. 1,804,848; Byull. Izobret., No. 12 (1993).
  • 115.Tolstikov GA, Baltina LA, Serdyuk NG, et al. Abstracts of Papers of the IVth Russian Nat. Congr. Man and Medicine. Moscow: RTs Farmedinfo; 1997. p. 207. [Google Scholar]
  • 116.O. A. Plyasunova, T. V. Il’ina, Ya. Yu. Kiseleva, et al., Vestn. Ross. Akad. Med. Nauk, No. 11, 42–46 (2004). [PubMed]
  • 117.Nasyrov Kh M. Synthesis and Preclinical Study of New Biologically Active Compounds. Ufa: Coll. Sci. Works BGMI; 1988. pp. 49–54. [Google Scholar]
  • 118.A. G. Pokrovskii, N. V. Fedyuk, S. M. Abdullaev, et al., RF Pat. Appl. No. 2003134868, Dec. 1, 2003.
  • 119.Nasyrov Kh M. Abstracts of Papers of the 1st Russian Nat. Congr.Man and Medicine. Moscow: RF Zdorov’e Cheloveka; 1992. p. 345. [Google Scholar]
  • 120.Nasyrov KhM, Chepurina LS, Kireeva RM. Eksp. Klin. Farmakol. 1995;58(6):60–63. [PubMed] [Google Scholar]
  • 121.L. A. Baltina, N. A. Somov, N. G. Serdyuk, and G. A. Tolstikov, RF Pat. No. 2,073,009 (1997).
  • 122.M. A. Mamon, Author’s Abstract of a Candidate Dissertation in Medical Sciences, Moscow (1998).
  • 123.Pokrovskii AG, Belanov EF, Volkov GN, et al. Dokl. Akad. Nauk. 1995;344(5):709–711. [PubMed] [Google Scholar]
  • 124.Hoever H, Baltina L, Michaelis M, et al. J. Med. Chem. 2005;48(4):1256–1259. doi: 10.1021/jm0493008. [DOI] [PubMed] [Google Scholar]
  • 125.L. A. Baltina, R. M. Kondratenko, L. R. Mikhailova, et al., in: Abstracts of the XVIIIth Int. Symp. on Medicinal Chemistry, Copenhagen, Denmark & Malmo, Sweden (2004); Drugs of the Future, 29(A), 86 (2004).
  • 126.Baran JS, Langford DD, Liang CD, et al. J. Med. Chem. 1973;17:184–190. doi: 10.1021/jm00248a008. [DOI] [PubMed] [Google Scholar]
  • 127.Dargan DJ, Subak-Sharpe JH. J. Gen. Virol. 1985;66:1771–1784. doi: 10.1099/0022-1317-66-8-1771. [DOI] [PubMed] [Google Scholar]
  • 128.D. E. Poswillo and G. J. Roberts, Lancet, 143–144 (1981). [DOI] [PubMed]
  • 129.S. Gottfried and L. Baxendale, Br. Pat. No. 843,133 (1960); Chem. Abstr., 55, 2027i (1960).
  • 130.Gheorghiu T, Frotz H, Klein HJ. Verh. Dtsch. Ges. Inn. Med. 1971;77:511–515. [PubMed] [Google Scholar]
  • 131.Colin-Jones DG, Lennard-Jones JE, Jones JH, et al. Symp. Carbenoxolone Sodium. London: Butterworths; 1967. [Google Scholar]
  • 132.I. Nakamura, Jpn. Pat. Appl. No. 61–165348 (1986); Ref. Zh. Khim., 16 O 125P (1987).
  • 133.Baron JH, Sullivan FM, editors. Carbenoxolone Sodium. London: Butterworths; 1970. [Google Scholar]
  • 134.E. Shanbrom, US Pat. No. 5,019,495, May 28, 1991; Chem. Abstr., 115, 202767j (1991).
  • 135.E. Shanbrom, PCT Int. Pat. Appl., WO 9005533, May 31, 1990; Chem. Abstr., 114, 88623m (1990).
  • 136.Robe PA, Princen F, Martin D, et al. Biochem. Pharmacol. 2000;60:241–249. doi: 10.1016/S0006-2952(00)00315-4. [DOI] [PubMed] [Google Scholar]
  • 137.Carrio M, Mazo A, Lopez-Iglesias C, et al. Int. J. Cancer. 2001;94(1):81–88. doi: 10.1002/ijc.1429. [DOI] [PubMed] [Google Scholar]
  • 138.Dargan DJ, Subak-Sharpe JH. J. Gen. Virol. 1986;67:1831–1850. doi: 10.1099/0022-1317-67-9-1831. [DOI] [PubMed] [Google Scholar]
  • 139.Pokrovskii AG, Plyasunova OA, Gashnikova NM, et al. Vopr. Virusol. 2001;6:38–42. [PubMed] [Google Scholar]
  • 140.Harada S, Maekawa T, Haneda E, et al. Biol. Pharm. Bull. 1998;21(12):1282–1285. doi: 10.1248/bpb.21.1282. [DOI] [PubMed] [Google Scholar]
  • 141.Cheng J-M, Lin H-J, Hsu Y-H, et al. Antiviral Res. 2004;62:27–36. doi: 10.1016/j.antiviral.2003.11.005. [DOI] [PubMed] [Google Scholar]
  • 142.Ohtsuki K, Iakida N. Biochem. Biophys. Res. Commun. 1988;157(2):597–604. doi: 10.1016/S0006-291X(88)80292-4. [DOI] [PubMed] [Google Scholar]
  • 143.Ohtsuki K, Kanno S, Ishida N. Igaku no Ayumi. 1989;148(2):113–114. [Google Scholar]
  • 144.A. Didkovskii, I. A. Zuikov, I. A. Malashenkova, A. N. Tanasova, and I. N. Shchepetkova, Rus. Med. Zh., 12(7) (2004); online: http://www.rmj.ru/articles378.htm.
  • 145.Pompei R, Marcialis MA. I. Ig. Mod. 1985;83:385–391. [Google Scholar]
  • 146.Ito K, Miyata M, Kosudo M, et al. Igaku no Ayumi. 1985;135(12/13):1089–1090. [Google Scholar]
  • 147.Sugawara I, Ishizaka S, Tsuji T, De Ley M. Nara Igaku Zasshi. 1984;35(4):424–429. [Google Scholar]
  • 148.Feng Y, Zhu T. Zhonghua Weishengwuxue He Mianyxue Zazhi. 1986;6(2):99–102. [Google Scholar]
  • 149.Kunano K, Munakata T, Semba U, et al. Igaku no Ayumi. 1984;129(3):173–175. [Google Scholar]
  • 150.Sakuma T, Voshida I, Shinada M, Azuma H. Igaku no Ayumi. 1983;127(6):669–671. [Google Scholar]
  • 151.Liang Z, Zhu T, Hang W. Zhongguo Yike Daxue Xuebao. 1991;20(4):257–259. [Google Scholar]
  • 152.Dargan DJ, Galt CB, Subak-Sharpe JH. J. Gen. Virol. 1992;73:397–406. doi: 10.1099/0022-1317-73-2-397. [DOI] [PubMed] [Google Scholar]
  • 153.Dargan DJ, Galt CB, Subak-Sharpe JH. J. Gen. Virol. 1992;73:407–411. doi: 10.1099/0022-1317-73-2-407. [DOI] [PubMed] [Google Scholar]
  • 154.Jeong HG, Kim JY. FEBS Lett. 2002;513:208–212. doi: 10.1016/S0014-5793(02)02311-6. [DOI] [PubMed] [Google Scholar]
  • 155.Lampis G, Ingianni A, Pompei R. Antiviral Res. 1997;36:191–195. doi: 10.1016/S0166-3542(97)00051-X. [DOI] [PubMed] [Google Scholar]
  • 156.M. Yamamoto, F. Norimitsu, and T. Sakamoto, Jpn. Pat. Appl. No. 1305021 (1989); Ref. Zh. Khim., 20 O 230P (1991).
  • 157.Fujisawa K, Watanabe Y, Kimura K. Asian Med. J. 1980;23(10):745–756. [Google Scholar]
  • 158.Suzuki H, Ohta Y, Takino T, et al. Asian Med. J. 1983;26(7):423–438. [Google Scholar]
  • 159.Iino S, Tango T, Matsushima T, et al. Hepatol. Res. 2001;19(1):31–40. doi: 10.1016/S1386-6346(00)00079-6. [DOI] [PubMed] [Google Scholar]
  • 160.Fujisawa K, Watanabe Y, Kimura K. Kan, Tan, Sui. 1983;7(3):369–379. [Google Scholar]
  • 161.Fujisawa K, Watanabe Y, Kitagawa T, et al. Shindan to Chiryo. 1984;76(2):726–732. [Google Scholar]
  • 162.Fujiyama S, Chikazawa H, Honda Y, et al. Biother. Jpn. 1998;12:1495–1513. [Google Scholar]
  • 163.Suzuki Y, Ikeda K, Saitoh S, et al. Acta Hepatol. Jpn. 1996;37:363–367. [Google Scholar]
  • 164.Okuno T, Arai K, Shindo M. Jpn. J. Clin. Med. 1995;53(9):1022–1025. [PubMed] [Google Scholar]
  • 165.Yamamoto Y, Yasuoka A, Tachikawa N, et al. Jpn. J. Infectious Dis. 1999;52(6):248–249. [PubMed] [Google Scholar]
  • 166.Tandon A, Tandon BN, Bhujwala RA. Hepatol. Res. 2001;20(1):1–8. doi: 10.1016/S1386-6346(00)00123-6. [DOI] [PubMed] [Google Scholar]
  • 167.R. Segal, S. Pisanty, and E. Azaz, GB Pat. No. 2,167,296, May 29, 1986; Chem. Abstr., 106, 55907p (1987).
  • 168.R. Segal, S. Pisanty, and E. Azaz, USA Pat. No. 4,678,772 (1988); Ref. Zh. Khim., 17 O 251P (1988).
  • 169.R. Segal, S. Pisanty, and E. Azaz, DE Pat. No. 3,443,242, May 28, 1986; Chem. Abstr., 105, 120776r (1986).
  • 170.R. Segal, S. Pisanty, and E. Azaz, Fr. Pat. No. 2,573,655 (1986); Ref. Zh. Khim., 14 O 243P (1987).
  • 171.Virucidal Mechanism of Action and Clinical Use [in Russian], Mezhdunarodnyi Mezhakademicheskii Soyuz i AMTN RF, Moscow (2002).
  • 172.Pomazanov VV, Koroleva Yu V. Glycyrrhizin-containing Preparations - New Effective Agent for Antiviral Therapy. Moscow: AMTN RF; 2001. [Google Scholar]
  • 173.Gonsales A. Prevencion y tratamiento tratammiento antitumoral, antiviral y de otras entermedactes degenerativas. Madrid: Catalysis, S. L.; 2001. p. 60. [Google Scholar]
  • 174.Hu ZH. Yaoxue Xuebao. 1988;23(7):553–560. [Google Scholar]
  • 175.Noirfalise A. From Licorice to Glycyrrhizin. Paris: Hommage Professeur Rene Truhaut, Fac. Pharm. Univ. Paris; 1984. pp. 818–821. [Google Scholar]
  • 176.Fan Y, Shi Z, He B. Tianran Chanwu Yanjiu Yu Kaifa. 1996;8(4):93–99. [Google Scholar]

Articles from Pharmaceutical Chemistry Journal are provided here courtesy of Nature Publishing Group

RESOURCES